Search for: "Schering Corp" Results 101 - 120 of 251
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Mar 2011, 8:09 am by Keith Reinfeld
On February 28, 2011, the United States Supreme Court denied the petition by Novartis and Schering Corp. to review the decision. [read post]
6 Mar 2011, 7:40 pm by Patent Docs
Schering Corp. et al.v. [read post]
1 Mar 2011, 1:34 pm by John Elwood
The Court relisted two new cases Monday, and most of last week’s relists are back for another trip to the Conference (all but Schering Corp v. [read post]
25 Feb 2011, 1:26 pm by Christa Culver
AllenDocket: 10-63Issue(s): (1) Whether the Eleventh Circuit properly held that the purported state procedural default rule is “adequate” as a matter of federal law to bar federal habeas review of serious constitutional claims and (2) whether the Eleventh Circuit properly held that there was no “cause” to excuse any procedural default where petitioner was blameless for the default, the state's own conduct contributed to the default, and petitioner's attorneys of… [read post]
23 Feb 2011, 9:52 am by John Elwood
§  Petition for certiorari §  Brief in opposition Title: Schering Corp. v. [read post]
8 Dec 2010, 10:42 am by FDABlog HPM
Geneva Pharms., Inc., 344 F.3d 1294, 1303 (11th Cir. 2003) and in Schering-Plough Corp. v. [read post]
9 Nov 2010, 3:09 pm
In October 1999, Schering Corp., the new exclusive licensee under the patent, filed for a patent term extension under 35 U.S.C. [read post]
2 Nov 2010, 1:57 pm by Kiran Bhat
The petition of the day is: Title: Schering Corp. v. [read post]
21 Sep 2010, 7:47 pm by Kelly
(FDA Law Blog) US: FDA set to announce public hearing on BPCI Act implementation (FDA Law Blog) US: Precision Biosciences granted stay pending reexam of Cellectis’ patents (Patent Docs) US: Celsis granted preliminary injunction against CellzDirect in LiverPool hepatocyte treatment infringement suit (Patent Docs) US: Yeda Research and Development files suit against Abbott in District of Columbia requesting review of BPAI decision (Patent Docs) Products Angiomax (Bivalirudin) – US: The… [read post]
31 Aug 2010, 10:01 pm by Kelly
– state of research and development of new drugs in Indian pharma industry (Spicy IP) US: The Financial Times’ take on gene patenting (Patent Docs) US: Seattle Biotech companies fight over allegedly similar names: Mirina Corp. v. [read post]